New Molecule May Open New Therapeutic Pathway Against Brain Cancer
Researchers at Brown University Health have identified a molecule that could potentially alter how glioblastoma responds to treatment. Glioblastoma is the deadliest and most prevalent form of brain cancer affecting adults, with a five-year survival rate of just 5%-10%. Planning is underway for a clinical trial testing direct surgical delivery of the molecule into the […]
